Literature DB >> 15520165

Breast cancer cells isolated by chemotaxis from primary tumors show increased survival and resistance to chemotherapy.

Sumanta Goswami1, Weigang Wang, Jeffrey B Wyckoff, John S Condeelis.   

Abstract

In this study, we have collected a migratory population of carcinoma cells by chemotaxis to epidermal growth factor-containing microneedles held in the primary tumor. The collected cells were subjected to microarray analysis for differential gene expression. The results show that anti-apoptotic genes are up-regulated and pro-apoptotic genes are down-regulated coordinately in the migratory subpopulation. Induction of apoptosis by doxorubicin, cisplatin, and etoposide in these cells demonstrates that they exhibit a lower drug-induced apoptotic index and lower cell death compared with carcinoma cells of the whole tumor. Our study indicates, for the first time, the capability of using a rat alograft model for evaluating the apoptotic status of a migratory subpopulation of tumor cells and the ability to study their resistance to chemotherapeutic agents directly. In addition, these results indicate that tumor cells that are chemotactic and migratory in response to epidermal growth factor in the primary tumor have a survival advantage over stationary tumor cells.

Entities:  

Mesh:

Year:  2004        PMID: 15520165     DOI: 10.1158/0008-5472.CAN-04-2027

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

Review 1.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

Review 2.  Metastasis: tumor cells becoming MENAcing.

Authors:  Frank Gertler; John Condeelis
Journal:  Trends Cell Biol       Date:  2010-11-09       Impact factor: 20.808

3.  Food microbial pathogen detection and analysis using DNA microarray technologies.

Authors:  Avraham Rasooly; Keith E Herold
Journal:  Foodborne Pathog Dis       Date:  2008-08       Impact factor: 3.171

4.  Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo.

Authors:  Sumanta Goswami; Ulrike Philippar; Daqian Sun; Antonia Patsialou; Jacob Avraham; Weigang Wang; Francesca Di Modugno; Paola Nistico; Frank B Gertler; John S Condeelis
Journal:  Clin Exp Metastasis       Date:  2008-11-05       Impact factor: 5.150

Review 5.  Divide or Conquer: Cell Cycle Regulation of Invasive Behavior.

Authors:  Abraham Q Kohrman; David Q Matus
Journal:  Trends Cell Biol       Date:  2016-09-12       Impact factor: 20.808

6.  A mathematical model for mesenchymal and chemosensitive cell dynamics.

Authors:  Anita Häcker
Journal:  J Math Biol       Date:  2011-03-25       Impact factor: 2.259

7.  Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis.

Authors:  Jeff H Tsai; Joana Liu Donaher; Danielle A Murphy; Sandra Chau; Jing Yang
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

8.  Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer.

Authors:  Evanthia T Roussos; Michele Balsamo; Shannon K Alford; Jeffrey B Wyckoff; Bojana Gligorijevic; Yarong Wang; Maria Pozzuto; Robert Stobezki; Sumanta Goswami; Jeffrey E Segall; Douglas A Lauffenburger; Anne R Bresnick; Frank B Gertler; John S Condeelis
Journal:  J Cell Sci       Date:  2011-07-01       Impact factor: 5.285

Review 9.  Signatures of breast cancer metastasis at a glance.

Authors:  George S Karagiannis; Sumanta Goswami; Joan G Jones; Maja H Oktay; John S Condeelis
Journal:  J Cell Sci       Date:  2016-04-15       Impact factor: 5.285

10.  Gene expression analysis of macrophages that facilitate tumor invasion supports a role for Wnt-signaling in mediating their activity in primary mammary tumors.

Authors:  Laureen S Ojalvo; Charles A Whittaker; John S Condeelis; Jeffrey W Pollard
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.